Article Figures & Data
Figures
- Fig 1.
Specific to IA, the preclinical phase between formation and symptom development/rupture can be quite variable, and the clinical phase between symptom development and SAH/death can be quite short or nonexistent. Lead time is dependent on screening frequency. DPCP indicates detectable preclinical phase. Adapted from Morrison65 by permission of Oxford University Press, USA.
Tables
Characteristics General Population ADPCKD Male/female distribution 71%–76% female 46%–58% female Aneurysm location 80%–90% anterior circulation 90%–100% anterior circulation Multiple aneurysms 35% 18%–31% - Table 2:
Five-year cumulative rupture rates from the ISUIA trial for patients without a history of SAH
Artery <7 mm 7–12 mm 13–24 mm ≥25 mm Cavernous carotid 0% 0% 3% 6.4% ACA/MCA/ICA 0% 2.6% 14.5% 40% PCA, PcomA, vertebrobasilar 2.5% 14.5% 18.4% 50% Note:—PCA indicates posterior cerebral artery; PcomA, posterior communicating artery; ACA, anterior cerebral artery.
